PatientSpotlight, by PanaceaIntelPatientSpotlight

Topic · Ophthalmology

Access

Coverage of who can actually get diagnosis and treatment - payer dynamics, geographic variation, infrastructure constraints, and the international divergence that defines real-world access. 2 pieces on access in Ophthalmology, newest first within each collection.

← All topics
FilterAll (58)Oncology (2)Rare Disease (8)Immunology (2)Neurology (25)Cardiometabolic (4)Respiratory (3)Women's Health (5)Mental Health (7)Ophthalmology (2)

Signals

2
SignalApr 26, 2026industry-filing · peer-reviewed

Glaucoma drug-delivery implant uptake reveals the procedure-room workflow constraint

Sustained-release glaucoma drug-delivery implants are addressing the chronic adherence problem that has characterised glaucoma management for decades. Real-world uptake reveals the procedure-room workflow as the principal access constraint.

TreatmentAccessDelivery
SignalApr 26, 2026registry · peer-reviewed

Geographic atrophy therapy uptake reveals the disease-monitoring infrastructure gap

Real-world uptake of complement C3 and C5 inhibitors for geographic atrophy has been slower and more variable than the pivotal trial benefit profile would have predicted. The drivers are disease-monitoring infrastructure, intravitreal-injection capacity, and the patient-and-clinician decision frame around a slowly progressive condition.

AccessDeliveryTreatment